75 years of Experience in Global Health
75 years of Experience in Global Health
The origins of Bioseutica extend back to 1947 with the birth of PROSPA Pharmaceutical Companies, Solar Group, and SPA, (Società Prodotti Antibiotici), which formed the foundation of what is today Bioseutica. In 2007 the shareholders of Bioseutica acquired Neova Technologies Inc. and its plants in Europe and Canada, a company specializing in the development and production of natural proteins and pancreatic enzymes.
Rodolfo Ferrari and Carlo Callerio founded the Italian company SPA (Società Prodotti Farmaceutici) to manufacture Penicillin and Lysozyme
Collaboration between SPA and Sir Alexander Fleming to develop a large scale Penicillin and Lysozyme production company
SPA established first lysozyme plant on industrial scale at NIVE Nunspeet The Netherlands
SPA estabilished Fordras SA specialized in Lysozyme API sales worldwide and R&D in Lugano Switzerland
Canadian Neova Technologies Inc. started Lysozyme production in Zeewolde The Netherlands; Starting cooperation with Kaken for developing the new polyen AMCIPATRICIN
Fordras SA spins off from Italian company SPA, LMC BV starts Lysozyme API and AMCIPATRICIN molecule production
Merger of Fordras and Neova Technologies under Bioseutica BV
Consolidation of egg white extraction in The Netherlands and pancreatic enzymes in Canada
Development of new products: NA2R® (2014) Entegard® (2016) AVIFORT (2018)
Acquisition of Belovo from BNL Food Group - Belgium
Bioseutica® (Fordras SA) lauches its First B2C product LYSOGUARD immune™
Bioseutica® establishes a new lysozyme plant in Ospel The Netherlands and celebrates 100 years of Lysozyme in Lugano with international guests and worldwide customers